close
close

Atrial septal occlusion devices market size, share and prospects

Atrial septal occlusion devices market size, share and prospects

Market overview
The global atrial septal covering device market is expected to register a high CAGR during the forecast period 2024-2031.
Atrial septal occlusion devices are implantable devices used to close atrial septal defects (ASDs) in the heart. They are used in cases where autistic disorders cause the right atrium or ventricle to enlarge, helping to prevent complications such as paradoxical embolism, left-to-right shunting and platypnea-orthodoxia syndrome. These devices improve heart function by effectively sealing the gap between the heart’s upper chambers.

Market dynamics
The need for atrial septal closure devices is driven by the high incidence of atrial septal defects (ASDs), particularly second-degree ASDs, which account for 80% of cases. Transcatheter device closure has become the preferred treatment for second-degree ASD and patent foramen ovale (PFO), providing a widely accepted alternative to surgical closure. Thanks to advances in devices and techniques, 80–90% of second-degree ASDs and all PFOs can now be closed percutaneously. Device selection depends on defect anatomy, device availability, long-term results, regulatory approvals, and physician preference.

Click here to get a sample copy of the Atrial Septal Covering Devices market report:-

https://www.datamintelligence.com/download-sample/atrial-septal-occluder-devices-market

Segment analysis

By product type
* Devices that weaken the interatrial septum
* Devices that weaken the interventricular septum
By the end user
* Hospitals and ambulatory surgical centers
*Specialized clinics

Main key players
WL Gore & Associates, Inc., Abbott Laboratories, Medtronic Plc, Endologix Inc., B. Braun Interventional Systems Inc, Meril Life Sciences Pvt. Ltd, Lepu Medical Technology (Beijing) Co., Ltd, CeraFlex, EUKON Srl and Boston Scientific Corp.

Related topics
Atrial fibrillation market – https://www.datamintelligence.com/research-report/atrial-fibrillation-market
Left Atrial Appendage (LAA) Device Market – https://www.datamintelligence.com/research-report/left-atrial-appendage-devices-market
Cardiac pacemaker developer market – https://www.datamintelligence.com/research-report/cardiology-pacemaker-programmer-market

Get customization in the report as per your requirements: https://www.datamintelligence.com/customize/atrial-septal-occluder-devices-market
Access the full report description, table of contents, table of figures, chart, etc. @ https://www.datamintelligence.com/research-report/atrial-septal-occluder-devices-market

Company name: DataM Intelligence
Contact person: Sai Kiran
E-mail: [email protected]
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a market research and consulting company that provides comprehensive business solutions to organizations, from research to consulting. At DataM Intelligence, we leverage our most important trademark trends, insights and achievements to provide fast and insightful solutions to clients like you. We offer a variety of syndicated and custom reports based on a solid methodology.
Our research database provides countless statistics and in-depth analysis across a wide range of over 6,300 reports in over 40 domains, creating business solutions for over 200 companies in over 50 countries; meeting the critical business research needs that drive the growth trajectory of our vast clientele.

This release was published on openPR.